14-21090934-C-T
Variant summary
Our verdict is Benign. Variant got -10 ACMG points: 0P and 10B. BP4_StrongBP6_ModerateBS2
The NM_016423.3(ZNF219):c.1771G>A(p.Ala591Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000861 in 1,393,970 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Consequence
NM_016423.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -10 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ZNF219 | NM_016423.3 | c.1771G>A | p.Ala591Thr | missense_variant | 5/5 | ENST00000360947.8 | NP_057507.2 | |
ZNF219 | NM_001101672.2 | c.1771G>A | p.Ala591Thr | missense_variant | 5/5 | NP_001095142.1 | ||
ZNF219 | NM_001102454.2 | c.1771G>A | p.Ala591Thr | missense_variant | 5/5 | NP_001095924.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ZNF219 | ENST00000360947.8 | c.1771G>A | p.Ala591Thr | missense_variant | 5/5 | 1 | NM_016423.3 | ENSP00000354206.3 | ||
ZNF219 | ENST00000421093.6 | c.1771G>A | p.Ala591Thr | missense_variant | 5/5 | 1 | ENSP00000392401.2 | |||
ZNF219 | ENST00000451119.6 | c.1771G>A | p.Ala591Thr | missense_variant | 5/5 | 5 | ENSP00000388558.2 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD3 exomes AF: 0.0000209 AC: 3AN: 143218Hom.: 0 AF XY: 0.0000383 AC XY: 3AN XY: 78312
GnomAD4 exome AF: 0.00000861 AC: 12AN: 1393970Hom.: 0 Cov.: 32 AF XY: 0.0000102 AC XY: 7AN XY: 688716
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 18, 2024 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at